series-b
Stage
2021
Founded
1
Investors
About
IASO Biotherapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies and biologic drugs for oncology and autoimmune diseases.
Explore IASO Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.